Ning Hou
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Epigenetics and DNA Methylation 7
- Signaling Pathways in Disease 6
- Peroxisome Proliferator-Activated Receptors 5
- Metabolism, Diabetes, and Cancer 5
-
- MicroRNA in disease regulation 6
- Co-authors
- Xiao Yi Yang (21 shared papers)Jiandong Luo (21 shared papers)Xuan Cheng (13 shared papers)Yan Teng (11 shared papers)Yilang Li (9 shared papers)Youyi Zhang (4 shared papers)Z H Li (6 shared papers)Cheng-Feng Luo (10 shared papers)
- Journals
- International Journal of Biological Sciences (5 papers)Frontiers in Pharmacology (4 papers)Clinical and Experimental Pharmacology and Physiology (3 papers)Circulation Research (3 papers)Cardiovascular Research (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ning Hou
111 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 527
- Molecular Biology 1.8k
- Cell Biology 322
- Cardiology and Cardiovascular Medicine 310
- Epidemiology 377
Countries citing papers authored by Ning Hou
This map shows the geographic impact of Ning Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Hou more than expected).
Fields of papers citing papers by Ning Hou
This network shows the impact of papers produced by Ning Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Hou. The network helps show where Ning Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 177 | |
| 2 | 2013 | 164 | |
| 3 | 2015 | 163 | |
| 4 | 2014 | 162 | |
| 5 | 2005 | 125 | |
| 6 | 2012 | 123 | |
| 7 | 2020 | 108 | |
| 8 | 2019 | 106 | |
| 9 | 2007 | 95 | |
| 10 | 2013 | 87 | |
| 11 | 2019 | 78 | |
| 12 | 2018 | 73 | |
| 13 | 2011 | 66 | |
| 14 | 2020 | 62 | |
| 15 | 2016 | 61 | |
| 16 | 2020 | 60 | |
| 17 | 1997 | 54 | |
| 18 | 2020 | 52 | |
| 19 | 2016 | 49 | |
| 20 | 2017 | 46 |
About Ning Hou
Ning Hou is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Cell Biology and Complementary and alternative medicine, having authored 123 papers that have together received 3.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Autophagy in Disease and Therapy (6 papers), MicroRNA in disease regulation (6 papers), Signaling Pathways in Disease (6 papers), Traditional Chinese Medicine Studies (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cardiac Fibrosis and Remodeling (5 papers). The work is most often cited by research in Cancer Research (527 citations), Molecular Biology (1.8k citations), Cell Biology (322 citations), Cardiology and Cardiovascular Medicine (310 citations) and Epidemiology (377 citations). Ning Hou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiao Yi Yang, Jiandong Luo, Xuan Cheng, Yan Teng, Yilang Li, Youyi Zhang, Z H Li, Cheng-Feng Luo, Faqian Li and Xiaoqing Chen. Their work appears in journals such as International Journal of Biological Sciences, Frontiers in Pharmacology, Clinical and Experimental Pharmacology and Physiology, Circulation Research and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.